This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. Credit: viewimage/Shutterstock.
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. Kennedy Jr.
June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The MoU was signed at the BIO International Convention 2025 in Boston, US. The MoU was signed at the BIO International Convention 2025 in Boston, in the US state of Massachusetts. Credit: Department of Health Abu Dhabi.
GlobalData Healthcare June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Changes to ACIP could result in regulatory uncertainty for vaccine developers and manufacturers. Credit: Melnikov Dimitriy via Shutterstock.
In a vote of 5 to 1 on Thursday, members of the Advisory Committee on Immunization Practices (ACIP) voted to recommend against influenza vaccine containing the preservative thimerosal. The recommendations include all US adults as well as recommending pregnant women also receive a thimerosal-free vaccine for influenza.
How will RFK Jr’s American dream for vaccines play out? Frankie Fattorini July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The EU Pharma Package’s attempt to balance priorities risks achieving none. Go deeper with GlobalData Reports Chemotherapy in Pharmaceuticals: Platinum-based cancer drug composi.
Completion Date (Estimated): May 2025 Lorundrostat is an oral, highly selective aldosterone synthase inhibitor (ASI) under development for the treatment of uncontrolled hypertension (uHTN) or resistant hypertension (rHTN), as well as CKD and obstructive sleep apnea. Updated February 21, 2025. Accessed June 17, 2025.
Published June 27, 2025 Meagan Parrish Lead Editor post share post print email license Justin Sullivan via Getty Images Listen to the article 7 min This audio is auto-generated. A long-time leader in vaccines, the U.K. By Michael Gibney • June 26, 2025 Keep up with the story. Please let us know if you have feedback.
A magnifying glass examining a vintage vaccine vial surrounded by four minimalistic chart icons, symbolizing healthcare, medicine, and analytics in the context of global health monitoring. Biosimilars continue to build as a sector of this market with an estimated 2025 value in the region of US$42 billion (1). Specifications.
GlobalData Healthcare June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook According to a Novo Nordisk’s speaker at the conference, the company aims to utilise human data input into its target discovery engine. Give your business an edge with our leading industry insights. Login Registration is disabled.
How will RFK Jr’s American dream for vaccines play out? July 2, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Merck executive board chair and CEO Belén Garijo. The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) also recommended its approval in June 2025.
It's cognitive behavioral therapy packaged as a digital experience. I've even seen VR experiences, so it can be packaged in any type of digital experience. Areo Nazari, PharmD: PDTs are digital or software-based treatments that are approved by the FDA to treat disease.
How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 2, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Analysis by GlobalData’s Pharma Intelligence Centre forecasts Alyftrek will bring in sales of $6.1bn by 2031. JHVEPhoto via Shutterstock. The pharma company has a market cap of $116bn.
From the Dilantin package insert: “The free acid form of phenytoin is used in DILANTIN-125 Suspension and DILANTIN Infatabs. 1, 2014 (accessed April 29, 2025). Drugs.com , last updated March 21, 2025 (accessed April 29, 2025). USDOJ.gov , May 2006 (accessed April 29, 2025). Pluta Nishant B. YouTube.com , Dec.
Zanubrutinib tablets are set to replace capsules beginning in October 2025, according to the news release. Released June 11, 2025. Accessed June 11, 2025. Package insert. Accessed June 11, 2025. FDA approves tablet formulation of BeOne's BRUKINSA for all approved indications. News Release. BeiGene USA, Inc.;
How will RFK Jr’s American dream for vaccines play out? July 2, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook BTCs include cholangiocarcinoma and gallbladder cancer. In March 2025, Jazz Pharmaceuticals signed an agreement to acquire Chimerix for $935m. Credit: mi_viri/Shutterstock.
How will RFK Jr’s American dream for vaccines play out? July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Piramal Pharma Solutions Lexington expansion groundbreaking. A ground-breaking ceremony was held on 25 June 2025 to mark the commencement of work on Lexington’s site expansion.
How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 3, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Future Pak is paying a cash premium of 126% on the last closing share closing price for the biopharma. Credit: SvetaZi via Shutterstock. Login Registration is disabled.
How will RFK Jr’s American dream for vaccines play out? Robert Barrie June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook CAR-Ts, the first of which were initially approved in June 2025, have demonstrated a wealth of efficacy in haematological oncology indications. Login Registration is disabled.
How will RFK Jr’s American dream for vaccines play out? June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Bird’s-eye view of the current Vetter site in Des Plaines where the clinical manufacturing facility will be built. Find out more Sign up for our daily news round-up!
How will RFK Jr’s American dream for vaccines play out? Uruguay’s new left-wing coalition government took office in March 2025, under President Yamandu Orsi. Credit: em_concepts via Shutterstock. Give your business an edge with our leading industry insights. Login Registration is disabled.
How will RFK Jr’s American dream for vaccines play out? July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The therapy can be administered either intravenously or subcutaneously. Credit: HenadziPechan/Shutterstock. Stay proactive with real-time data and expert analysis. Login Registration is disabled.
Robert Barrie June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Gavi conducted a fundraiser at its annual Global Summit held in Brussels on 25 June. The Gates Foundation committed $1.6bn for the vaccine alliance, making it the second largest donor. Credit: speedshutter Photography via Shutterstock.
How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 2, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Yeztugo, injected twice a year, offers more convenient dosing than daily pills. Credit: Marc Bruxelle via Shutterstock. Give your business an edge with our leading industry insights.
How will RFK Jr’s American dream for vaccines play out? July 2, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Adagene will provide Sanofi with muzastotug for the evaluation of its safety, efficacy, pharmacokinetics and biomarker data. Give your business an edge with our leading industry insights.
How will RFK Jr’s American dream for vaccines play out? June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition will provide Torrent with access to a fast-growing Indian franchise and new therapeutic areas such as ophthalmology. Give your business an edge with our leading industry insights.
GlobalData Healthcare June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Surovatamig’s global sales are projected to reach $138 million by 2031. GlobalData Healthcare June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Surovatamig’s global sales are projected to reach $138 million by 2031.
How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 1, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Shares in NYSE-listed AbbVie closed 1.7% higher following the deal. Valeriya Zankovych via Shutterstock. Give your business an edge with our leading industry insights.
How will RFK Jr’s American dream for vaccines play out? July 4, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Vevzuo is authorised to prevent bone complications in adults with advanced cancer in bone and treat GCT of bone. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate?
Robert Barrie June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The positive opinion issued by the EMA’s Committee for Medicinal Products for Human Use (CHMP) signals a strong chance that its drug will be approved. A decision is expected in August 2025. Login Registration is disabled.
How will RFK Jr’s American dream for vaccines play out? July 3, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Pelthos will focus on launching and commercialising Zelsuvmi topical gel for molluscum contagiosum infections. Find out more Part of this investment involved the cancellation of $18.8m
Robert Barrie June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The collaboration, set to begin on 1 July, will see Novo Nordisk team up with the telehealth company to offer Wegovy to customers. After the first month, this will rise to $499. A separate limited-time offer of $199 is also available until 30 June.
How will RFK Jr’s American dream for vaccines play out? July 3, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Shionogi will hold an exclusive option to license the molecules for further clinical development. Credit: Egoreichenkov Evgenii/Shutterstock. Give your business an edge with our leading industry insights.
June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company intends to introduce its inaugural product candidate into clinical trials by 2026. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.
How will RFK Jr’s American dream for vaccines play out? Robert Barrie July 3, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Regeneron’s drug joins two fellow BCMAxCD3 bispecific antibodies already at market in the US. Credit: lev radin via Shutterstock. Login Registration is disabled.
How will RFK Jr’s American dream for vaccines play out? July 2, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Logistics is crucial for successful cell and gene therapy treatments. Credit: via Shutterstock. Login Registration is disabled.
How will RFK Jr’s American dream for vaccines play out? July 4, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook BRII-693 is a potential solution for patients with multidrug-resistant and extensively drug-resistant gram-negative bacterial infections. Give your business an edge with our leading industry insights.
How will RFK Jr’s American dream for vaccines play out? July 4, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook AstraZeneca will use Modella AI’s platform for cancer research and development. Credit: Inna Dodor/Shutterstock. Give your business an edge with our leading industry insights.
June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Metabolic dysfunction-associated steatohepatitis is a chronic liver condition. In May 2025, Boehringer partnered Tempus AI to develop a cancer therapy pipeline. Sign up for our daily news round-up! Give your business an edge with our leading industry insights.
Robert Barrie June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook RFK Jr axed all 17 members belonging to the previous committee earlier this week. ACIP is the committee responsible for reviewing vaccine data and issuing official government recommendations on immunisations. Credit: LightRocket via Getty Images.
How will RFK Jr’s American dream for vaccines play out? July 3, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Zegfrovy is approved to treat NSCLC patients with EGFR exon 20 insertion mutations. Credit: Arif biswas/Shutterstock. Give your business an edge with our leading industry insights.
June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The treatments can be accessed through facilities such as Royal Prince Alfred Hospital, Westmead Hospital and the Sydney Children’s Hospitals Network. Give your business an edge with our leading industry insights. Login Registration is disabled.
June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook In March 2018, Health Canada approved Novartis’ therapy to treat individuals with HR+/HER2- advanced or metastatic breast cancer. “We In March 2018, Health Canada approved the therapy to treat individuals with HR+/HER2- advanced or metastatic breast cancer.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content